258 related articles for article (PubMed ID: 28159925)
1. miRNA-1246 induces pro-inflammatory responses in mesenchymal stem/stromal cells by regulating PKA and PP2A.
Bott A; Erdem N; Lerrer S; Hotz-Wagenblatt A; Breunig C; Abnaof K; Wörner A; Wilhelm H; Münstermann E; Ben-Baruch A; Wiemann S
Oncotarget; 2017 Jul; 8(27):43897-43914. PubMed ID: 28159925
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.
Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A
Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089
[TBL] [Abstract][Full Text] [Related]
3. Tumor-Stroma-Inflammation Networks Promote Pro-metastatic Chemokines and Aggressiveness Characteristics in Triple-Negative Breast Cancer.
Liubomirski Y; Lerrer S; Meshel T; Rubinstein-Achiasaf L; Morein D; Wiemann S; Körner C; Ben-Baruch A
Front Immunol; 2019; 10():757. PubMed ID: 31031757
[TBL] [Abstract][Full Text] [Related]
4. miR-155-5p inhibition promotes the transition of bone marrow mesenchymal stem cells to gastric cancer tissue derived MSC-like cells via NF-κB p65 activation.
Zhu M; Wang M; Yang F; Tian Y; Cai J; Yang H; Fu H; Mao F; Zhu W; Qian H; Xu W
Oncotarget; 2016 Mar; 7(13):16567-80. PubMed ID: 26934326
[TBL] [Abstract][Full Text] [Related]
5. IL-1β produced by aggressive breast cancer cells is one of the factors that dictate their interactions with mesenchymal stem cells through chemokine production.
Escobar P; Bouclier C; Serret J; Bièche I; Brigitte M; Caicedo A; Sanchez E; Vacher S; Vignais ML; Bourin P; Geneviève D; Molina F; Jorgensen C; Lazennec G
Oncotarget; 2015 Oct; 6(30):29034-47. PubMed ID: 26362269
[TBL] [Abstract][Full Text] [Related]
6. COX-2 Elevates Oncogenic miR-526b in Breast Cancer by EP4 Activation.
Majumder M; Landman E; Liu L; Hess D; Lala PK
Mol Cancer Res; 2015 Jun; 13(6):1022-33. PubMed ID: 25733698
[TBL] [Abstract][Full Text] [Related]
7. Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer.
Liubomirski Y; Lerrer S; Meshel T; Morein D; Rubinstein-Achiasaf L; Sprinzak D; Wiemann S; Körner C; Ehrlich M; Ben-Baruch A
Front Immunol; 2019; 10():804. PubMed ID: 31105691
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients.
De Mattos-Arruda L; Bottai G; Nuciforo PG; Di Tommaso L; Giovannetti E; Peg V; Losurdo A; Pérez-Garcia J; Masci G; Corsi F; Cortés J; Seoane J; Calin GA; Santarpia L
Oncotarget; 2015 Nov; 6(35):37269-80. PubMed ID: 26452030
[TBL] [Abstract][Full Text] [Related]
10. miR-200c dampens cancer cell migration via regulation of protein kinase A subunits.
Sigloch FC; Burk UC; Biniossek ML; Brabletz T; Schilling O
Oncotarget; 2015 Sep; 6(27):23874-89. PubMed ID: 26203557
[TBL] [Abstract][Full Text] [Related]
11. Lung tumor exosomes induce a pro-inflammatory phenotype in mesenchymal stem cells via NFκB-TLR signaling pathway.
Li X; Wang S; Zhu R; Li H; Han Q; Zhao RC
J Hematol Oncol; 2016 Apr; 9():42. PubMed ID: 27090786
[TBL] [Abstract][Full Text] [Related]
12. TNFalpha up-regulates SLUG via the NF-kappaB/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype.
Storci G; Sansone P; Mari S; D'Uva G; Tavolari S; Guarnieri T; Taffurelli M; Ceccarelli C; Santini D; Chieco P; Marcu KB; Bonafè M
J Cell Physiol; 2010 Nov; 225(3):682-91. PubMed ID: 20509143
[TBL] [Abstract][Full Text] [Related]
13. Annexin-A1 regulates microRNA-26b* and microRNA-562 to directly target NF-κB and angiogenesis in breast cancer cells.
Anbalagan D; Yap G; Yuan Y; Pandey VK; Lau WH; Arora S; Bist P; Wong JS; Sethi G; Nissom PM; Lobie PE; Lim LH
PLoS One; 2014; 9(12):e114507. PubMed ID: 25536365
[TBL] [Abstract][Full Text] [Related]
14. Notch-1 signaling activates NF-κB in human breast carcinoma MDA-MB-231 cells via PP2A-dependent AKT pathway.
Li L; Zhang J; Xiong N; Li S; Chen Y; Yang H; Wu C; Zeng H; Liu Y
Med Oncol; 2016 Apr; 33(4):33. PubMed ID: 26945854
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cells and macrophages interact through IL-6 to promote inflammatory breast cancer in pre-clinical models.
Wolfe AR; Trenton NJ; Debeb BG; Larson R; Ruffell B; Chu K; Hittelman W; Diehl M; Reuben JM; Ueno NT; Woodward WA
Oncotarget; 2016 Dec; 7(50):82482-82492. PubMed ID: 27756885
[TBL] [Abstract][Full Text] [Related]
16. In Vitro Fusion of Normal and Neoplastic Breast Epithelial Cells with Human Mesenchymal Stroma/Stem Cells Partially Involves Tumor Necrosis Factor Receptor Signaling.
Melzer C; von der Ohe J; Hass R
Stem Cells; 2018 Jul; 36(7):977-989. PubMed ID: 29569804
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA expression profiling of human bone marrow mesenchymal stem cells during osteogenic differentiation reveals Osterix regulation by miR-31.
Baglìo SR; Devescovi V; Granchi D; Baldini N
Gene; 2013 Sep; 527(1):321-31. PubMed ID: 23827457
[TBL] [Abstract][Full Text] [Related]
18. A negative feedback loop between miR-200b and the nuclear factor-κB pathway via IKBKB/IKK-β in breast cancer cells.
Wu H; Wang G; Wang Z; An S; Ye P; Luo S
FEBS J; 2016 Jun; 283(12):2259-71. PubMed ID: 26433127
[TBL] [Abstract][Full Text] [Related]
19. Pre-treatment of human umbilical cord-derived mesenchymal stem cells with interleukin-6 abolishes their growth-promoting effect on gastric cancer cells.
Wang M; Cai J; Huang F; Zhu M; Zhang Q; Yang T; Zhang X; Qian H; Xu W
Int J Mol Med; 2015 Feb; 35(2):367-75. PubMed ID: 25483835
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.
Rasheed SA; Teo CR; Beillard EJ; Voorhoeve PM; Zhou W; Ghosh S; Casey PJ
Mol Cancer; 2015 Mar; 14():67. PubMed ID: 25889182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
